Clinical Trial Update: Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating the addition of asciminib to standard treatment for adults with newly diagnosed Philadelphia chromosome-positive acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia, CD19+ Acute Leukemia | Phase 2 | Status: ENROLLING_BY_INVITATION